Assessing homogeneity in workplace exposure under stationary and non-stationary scenarios

In most epidemiological studies, historical monitoring data are scant and must be pooled to identify occupational groups with homogeneous exposures. Homogeneity of exposure is generally assessed in a group of workers who share a common job title or work in a common area. While published results suggest that the degree of homogeneity varies widely across job groups, less is known whether such variation differs across industrial sectors, classes of contaminants, or in the methods used to group workers. Relying upon a compilation of results presented in the literature, patterns of homogeneity among nearly 500 occupational groups of workers were evaluated on the basis of type of industry and agent. Additionally, effects of the characteristics of the sampling strategy on estimated indicators of homogeneity of exposure were assessed. ^ Exposure profiles for occupational groups of workers have typically been assessed under the assumption of stationarity, i.e., the mean exposure level and variance of the distribution that describes the underlying population of exposures are constant over time. Yet, the literature has shown that occupational exposures have declined in the last decades. This renders traditional methods for the description of exposure profiles inadequate. Thus, work was needed to develop appropriate methods to assess homogeneity for groups of workers whose exposures have changed over time. A study was carried out applying mixed effects models with a term for temporal trend to appropriately describe exposure profiles of groups of workers in the nickel-producing industry over a 20-year period. Using a sub-set of groups of nickel-exposed workers, another study was conducted to develop and apply a framework to evaluate the assumption of stationarity of the variances in the presence of systematic changes in exposure levels over time. ^

Regulation of phosphatidylinositide turnover in the myometrium by cAMP: Implications for the control of uterine contraction

Regulation of uterine quiescence involves the integration of the signaling pathways regulating uterine contraction and relaxation. Uterine contractants increase intracellular calcium through receptor/GαqPLC coupling, resulting in contraction of the myometrium. Elevation of cAMP concentration has been correlated with relaxation of the myometrium. However, the mechanism of cAMP action in the uterus is unclear. ^ Both endogenous and exogenous increases in cAMP inhibited oxytocin-stimulated phosphatidylinositide turnover in an immortalized pregnant human myometrial cell line (PHM1-41). This inhibition was reversed by cAMP-dependent protein kinase (PKA) inhibitors, suggesting the involvement of PKA. cAMP inhibited phosphatidyinositide turnover stimulated by different agonists in different cell lines. These data suggest that the cAMP inhibitory mechanism is neither cell nor receptor dependent, and inhibits Gαq/PLCβ1 and PLCβ3 coupling. ^ The subcellular localization of PKA occurs via PKA binding to A-Kinase-Anchoring-Proteins (AKAP), and peptides that inhibit this association have been developed (S-Ht31). S-Ht31 blocked cAMP-stimulated PKA activity and decreased PKA concentration in PHM1-41 cell plasma membranes. S-Ht31 reversed the ability of CPT-cAMP, forskolin and relaxin to inhibit phosphatidylinositide turnover in PHM1-41 cells. Overlay analysis of both PHM1-41 cell and nonpregnant rat myometrium found an AKAPs of 86 kDa and 150 kDa associated with the plasma membrane, respectively. These data suggest that PKA anchored to the plasma membrane via AKAP150/PKA anchoring is involved in the cAMP inhibitory mechanism. ^ CPT-cAMP and isoproterenol inhibited phosphatidylinositide turnover in rat myometrium from days 12 through 20 of gestation. In contrast, neither agent was effective in the 21 day pregnant rat myometrium. The decrease in the cAMP inhibitory mechanism was correlated with a decrease in PKA and an increase in protein phosphatase 2B (PP2B) concentration in rat myometrial plasma membranes on day 21 of gestation. In myometrial total cell homogenates, both PKA and PP2B concentration increased on day 21. S-Ht31 inhibited cAMP inhibition of phosphatidylinositide turnover in day 19 pregnant rat myometrium. Both PKA and PP2B coimmunoprecipitated with an AKAP150 in a gestational dependent manner, suggesting this AKAP localizes PKA and PP2B to the plasma membrane. ^ These data presented demonstrate the importance of the cAMP inhibitory mechanism in regulating uterine contractility. ^